Stocks
Halozyme Therapeutics, Inc.HALO
NASDAQHealthcareBiotechnology$63.66+0.16%
A biotechnology company focused on drug‑delivery technologies that enable injectable biologic medicines to be administered subcutaneously rather than through traditional intravenous infusion. Its proprietary ENHANZE platform is licensed to major pharmaceutical partners, generating milestone payments...
Market Cap: $7.5B52W Range: $47.50 – $82.22
Congressional Interest in Halozyme Therapeutics, Inc. (HALO)
4 members of Congress have disclosed 9 trades in Halozyme Therapeutics, Inc. (HALO), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 6 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
9
Unique Politicians
4
Buys
3
Sells
6
Who in Congress Is Trading HALO?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-03-24 | Gilbert Cisneros | sell | $1K – $15K |
| 2024-09-09 | Josh Gottheimer | sell | $1K – $15K |